Risk stratification using human papillomavirus testing among women with equivocally abnormal cytology: Results from a state-wide surveillance program

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 1, 2016, Pages 36-42

  Gage, Julia C ^a   Hunt, William C ^b   Schiffman, Mark ^a   Katki, Hormuzd A ^a   Cheung, Li C ^c   Cuzick, Jack ^d   Myers, Orrin ^b   Castle, Philip E ^e   Wheeler, Cosette M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; CANCER GRADING; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; COMPLICATION; CYTODIAGNOSIS; EARLY CANCER DIAGNOSIS; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; TUMOR INVASION; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POPULATION SURVEILLANCE; PROGNOSIS; RISK ASSESSMENT; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84955237859     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0669     Document Type: Article

References (23)

1. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013;121:829-46.
2. + risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. JLGTD 2013;17:S28-35.
3. + and cervical cancer among women with HPV testing of ASC-US Pap results. J Lower Genit Tract Dis 2013;17:S36-42.
4. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. AmerJ Obstet and Gynecol 2003;188:1383-92.
5. Stoler MH, Wright TC Jr., Sharma A, Apple R, Gutekunst K, Wright TL. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol 2011;135:468-75.
6. Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 2011;12:663-72.
7. Cuzick J, Myers O, Hunt WC, Robertson M, Joste NE, Castle PE, et al. A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev 2014;23:765-73.
8. nmhealth.org [internet]. New Mexico Notifiable disease or conditions. In: Health NMDo, editor. [cited 2015 February 29]. Available from: http://nmhealth.org/publication/view/regulation/372/2012.
9. Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Pearse A, Montoya GD, et al. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer 2013;132:198-207.
10. Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: a population-based study of opportunistic cervical screening in the United States. Int J Cancer 2014;135:624-34.
11. Kaplan IW, Meier R. Submucous lipoma of the colon. Amer J Gastro 1959;31:673-83.
12. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008;337:a1754.
13. Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, et al. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev 2011;20:1398-409.
14. Lawless JF. Statistical models and methods for lifetime data. 2nd ed. Hoboken N.J.: Wiley-Interscience; 2003.
15. Turnbull B. The empirical distribution function with arbitrarily grouped, censored and truncated data. J Roy Stat Soc B 1976;38:290-5.
16. Gage JC, Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, et al. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management. Cancer Cytopathol 2014;122:842-50.
17. Rositch AF, Silver MI, Burke A, Viscidi R, Chang K, Duke CM, et al. The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women. J Lower Genit Tract Dis 2013;17:38-47.
18. Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011;121:4593-9.
19. + among women with HPV-positive and HPV-negative LSIL Pap results. J Low Genit Tract Dis 2013;17:S43-9.
20. Wright TC Jr., Stoler MH, Behrens CM, Sharma A, Sharma K, Apple R. Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial. Int J Cancer 2014;134:1835-43.
21. Castle PE, Stoler MH, Wright TC, Jr., Sharma A, Wright TL, Behrens CM. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 2011;12:880-90.
22. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400.
23. Campion MJ, McCance DJ, Cuzick J, Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986;2:237-40.